10-Q: Bespoke Extracts Inc. Reports Increased Sales but Continues to Face Going Concern Challenges in Q1 2024

Bespoke Extracts, Inc. saw a significant increase in sales during the first quarter of 2024, but continues to operate with a working capital deficit and negative cash flows, raising concerns about its ability to continue as a going concern.

Summary

• Bespoke Extracts, Inc. reported a net loss of $314,118 for the three months ended March 31, 2024, compared to a net loss of $440,620 for the same period in 2023.
• Sales increased significantly to $260,428 in Q1 2024 from $89,016 in Q1 2023, primarily due to increased direct sales of pre-rolled joints.
• The company's cost of goods sold also increased to $157,847 in Q1 2024 from $78,667 in Q1 2023, but as a percentage of sales, it decreased due to improved efficiencies.
• Operating expenses decreased slightly to $405,384 in Q1 2024 from $453,719 in Q1 2023, mainly due to a reduction in stock-based compensation.
• As of March 31, 2024, the company had a cash balance of $14,416 and a working capital deficit of $1,241,535.
• The company's current liabilities totaled $1,345,306, including accounts payable, accrued liabilities, and lease obligations.
• The company's ability to continue as a going concern is dependent on generating profitable operations or securing additional financing.
• The company has a significant accumulated deficit of $25,680,759 as of March 31, 2024.

Sentiment

Score: 4

Explanation: The document shows some positive signs with increased sales, but the significant financial challenges, including the going concern issue and negative cash flows, heavily weigh down the overall sentiment. The company's reliance on related party loans and the need for additional capital raise further contribute to the negative outlook.

Positives

• The company experienced a substantial increase in sales, indicating growing market traction for its products.
• The net loss decreased compared to the same period last year, suggesting improved operational efficiency or cost management.
• The company has secured additional financing through the issuance of secured notes and warrants.

Negatives

• The company continues to operate with a significant working capital deficit, indicating potential liquidity issues.
• The company has negative cash flows from operations, raising concerns about its ability to sustain operations without additional funding.
• The company has a substantial accumulated deficit, highlighting its history of losses.
• The company's financial statements are prepared under the assumption of a going concern, which is in doubt due to its financial situation.
• The company relies heavily on related party loans, which may not be sustainable in the long term.

Risks

• The company's ability to continue as a going concern is uncertain due to negative cash flows and a working capital deficit.
• The company may not be able to secure additional financing on acceptable terms, which could force it to curtail or cease operations.
• The company's reliance on related party loans poses a risk if those loans are not available in the future.
• The company's internal controls are not effective, which could lead to errors or irregularities in financial reporting.
• The company is exposed to market risks, including fluctuations in demand for its products and changes in the regulatory environment.

Future Outlook

The company's future is dependent on generating profitable operations or obtaining necessary financing, with no assurance that these will be achieved. The company may need to curtail or cease operations if additional financing is not available.

Management Comments

• Management acknowledges the substantial doubt about the company's ability to continue as a going concern.
• Management states that the company plans to expand its focus to regulated cannabis markets in the United States.
• Management notes that the increase in sales was due to increased direct sales of pre-rolled joints to licensed dispensaries in Colorado.

Industry Context

The company operates in the regulated cannabis market, which is subject to evolving regulations and market dynamics. The company's focus on marijuana-infused products aligns with the growing demand for these products in states with legal cannabis markets. The company's financial challenges are not uncommon for smaller companies in this sector, which often face high operating costs and regulatory hurdles.

Comparison to Industry Standards

• Comparing Bespoke Extracts to other small cannabis companies, the sales growth is a positive sign, but the negative cash flow and going concern issues are common challenges.
• Companies like Aurora Cannabis and Canopy Growth, while larger, have also faced profitability issues, highlighting the difficulty in achieving sustainable profitability in the cannabis industry.
• Bespoke's reliance on related party loans is a common practice for early-stage companies, but it also indicates a lack of access to traditional financing, which is a risk factor.
• The company's internal control weaknesses are not uncommon for smaller companies with limited resources, but they need to be addressed to ensure accurate financial reporting.

Related Party Transactions

• The company received additional advances from Infinity Management, LLC, an affiliate of the CEO, totaling $5,000 during the three months ended March 31, 2024.
• The company's CEO, Michael Feinsod, is owed $907,872 as of March 31, 2024, for loans and advances.
• The company converted $849,500 of notes payable into a 5% interest-bearing note due June 30, 2025, with Infinity Management, LLC.
• The company's CEO, Michael Feinsod, is owed a total of $253,938 of accrued salary and accounts payable of $156,944.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern issues and potential dilution from future equity raises.
• Employees may be impacted by potential layoffs or operational changes if the company cannot secure additional funding.
• Customers may be affected by potential disruptions in product availability if the company faces financial difficulties.
• Creditors face the risk of non-payment if the company's financial situation does not improve.

Next Steps

• The company needs to secure additional financing to continue operations.
• The company needs to improve its internal controls over financial reporting.
• The company needs to focus on generating positive cash flows from operations.
• The company needs to continue to expand its sales and market presence.

Key Dates

Keywords

cannabis, marijuana, extracts, financial results, going concern, secured notes, warrants, operating loss, sales growth, related party transactions